| payload |
{"created_at":"2026-04-17T21:52:12.771 {"created_at":"2026-04-17T21:52:12.771882+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/better-long-term-buy-eli-lilly-or-viking-therapeutics","value":{"fp":"e114829e77bd823e","kind":"unusual_volume","published_at":"2026-04-17T21:04:27+00:00","source":"Nasdaq Markets","summary":"Key PointsEli Lilly has been a growth beast, coming off an impressive year in which its revenue rose by 45%.","tickers":[],"title":"Better Long-Term Buy: Eli Lilly or Viking Therapeutics?","url":"https://www.nasdaq.com/articles/better-long-term-buy-eli-lilly-or-viking-therapeutics"}}... |